Research ArticleArticle
Pharmacological Characterization and Modeling of the Binding Sites of Novel 1,3-Bis(pyridinylethynyl)benzenes as Metabotropic Glutamate Receptor 5-Selective Negative Allosteric Modulators
Christina Mølck, Kasper Harpsøe, David E. Gloriam, Rasmus P. Clausen, Ulf Madsen, Lars Ø. Pedersen, Hermogenes N. Jimenez, Søren M. Nielsen, Jesper M. Mathiesen and Hans Bräuner-Osborne
Molecular Pharmacology November 2012, 82 (5) 929-937; DOI: https://doi.org/10.1124/mol.112.078808
Christina Mølck
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Kasper Harpsøe
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
David E. Gloriam
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Rasmus P. Clausen
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Ulf Madsen
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Lars Ø. Pedersen
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Hermogenes N. Jimenez
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Søren M. Nielsen
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Jesper M. Mathiesen
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)
Hans Bräuner-Osborne
Department of Drug Design and Pharmacology, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (C.M., D.E.G., R.P.C., U.M., J.M.M., H.B.-O.); NNF Center for Protein Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (K.H.); Department for Biologics (L.Ø.P.) and Department of Molecular Pharmacology (S.M.N.), H. Lundbeck A/S, Valby, Denmark; and Department of Chemical and Pharmacokinetic Science, Lundbeck Research USA, Paramus, New Jersey (H.N.J.)

MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
Research ArticleArticle
Binding Site Characterization of Novel NAMs on mGluR5
Christina Mølck, Kasper Harpsøe, David E. Gloriam, Rasmus P. Clausen, Ulf Madsen, Lars Ø. Pedersen, Hermogenes N. Jimenez, Søren M. Nielsen, Jesper M. Mathiesen and Hans Bräuner-Osborne
Molecular Pharmacology November 1, 2012, 82 (5) 929-937; DOI: https://doi.org/10.1124/mol.112.078808
Research ArticleArticle
Binding Site Characterization of Novel NAMs on mGluR5
Christina Mølck, Kasper Harpsøe, David E. Gloriam, Rasmus P. Clausen, Ulf Madsen, Lars Ø. Pedersen, Hermogenes N. Jimenez, Søren M. Nielsen, Jesper M. Mathiesen and Hans Bräuner-Osborne
Molecular Pharmacology November 1, 2012, 82 (5) 929-937; DOI: https://doi.org/10.1124/mol.112.078808
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement